ENTITY

Turning Point Therapeutics I (TPTX US)

Analysis

Health Care • United States

Turning Point Therapeutics, Inc. operates as a biopharmaceutical company. The Company designs and develops novel small molecule to treat cancer related diseases. Turning Point Therapeutics serves medical sector in the United States.

Refresh

Focused

No publications yet

There aren’t any podcasts right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00